carbodiimides has been researched along with Neoplasms in 4 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Daoud, J; Martel, S; Mohammadi, M; Tabrizian, M; Taherkhani, S | 1 |
| Santra, S | 1 |
| Alonso, CM; Boyle, RW; Bullous, AJ | 1 |
| Abdou, WM; Barghash, RF; Bekheit, MS | 1 |
1 review(s) available for carbodiimides and Neoplasms
| Article | Year |
|---|---|
Photosensitiser-antibody conjugates for photodynamic therapy.
Topics: Acrylamides; Antibodies; Carbodiimides; Fullerenes; Humans; Isothiocyanates; Neoplasms; Photochemotherapy; Photosensitizing Agents; Polyglutamic Acid; Polyvinyl Alcohol | 2011 |
3 other study(ies) available for carbodiimides and Neoplasms
| Article | Year |
|---|---|
Covalent binding of nanoliposomes to the surface of magnetotactic bacteria for the synthesis of self-propelled therapeutic agents.
Topics: Alphaproteobacteria; Animals; Antineoplastic Agents; Bacteria; Biocompatible Materials; Carbodiimides; Cell Line, Tumor; Cell Separation; Diffusion; Dose-Response Relationship, Drug; Drug Carriers; Flow Cytometry; Genetic Vectors; Humans; Inhibitory Concentration 50; Liposomes; Magnetics; Mice; Microscopy, Confocal; Nanoparticles; Nanotechnology; Neoplasms; NIH 3T3 Cells; Protein Binding | 2014 |
Fluorescent silica nanoparticles for cancer imaging.
Topics: Antibodies, Neoplasm; Aptamers, Nucleotide; Avidin; Biotin; Carbodiimides; Cyanogen Bromide; Dextrans; Diagnostic Imaging; Disulfides; Drug Delivery Systems; Emulsions; Ethanol; Fluorescence; Nanomedicine; Nanoparticles; Neoplasms; Particle Size; Silicon Dioxide; Surface Properties; Water | 2010 |
Carbodiimides in the synthesis of enamino- and α-aminophosphonates as peptidomimetics of analgesic/antiinflammatory and anticancer agents.
Topics: Analgesics; Animals; Anti-Inflammatory Agents; Antineoplastic Agents; Carbodiimides; Cell Line, Tumor; Disease Models, Animal; Drug Stability; Humans; Inflammation; Male; Mice; Neoplasms; Organophosphonates; Pain; Peptidomimetics; Structure-Activity Relationship | 2012 |